Evaluation of the Clinical Specificity of the Active Anthrax Detect™ Plus (AAD Plus) Lateral Flow Immunoassay (LFI)

Completed

Conditions studied: Anthrax

In brief

The primary objective of the study is to determine the estimated clinical specificity of the AAD Plus. A secondary objective is to determine the estimated sensitivity of the AAD Plus as 10% of the study subject samples will be contrived to be positive.

Key facts

Study ID

NCT04320485

Run by

InBios International, Inc.

People needed

450

Starts

2020-03-25

Expected to finish

2020-12-17

Last updated by the study team

2021-02-10

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, 18 to 90 years of age.
• Current symptoms consistent with cold, flu or other bronchial and febrile infections. The subject must currently (day of consent) have at least one of the following symptoms: fever, chills, chest discomfort, shortness of breath, cough, dizziness/confusion, nausea, headache, sweats, fatigue, or body aches.

You may not qualify if…

• Nursing home residents
• Inmates/subjects in police custody
• Unable to understand verbal or written language of the consent or require a Legal Authorized Representative for consent

Where it is running

• Fiel Family and Sports Medicine/CCT Research — Tempe, Arizona, United States
• Hometown Urgent Care and Research — Cincinnati, Ohio, United States
• Hometown Urgent Care and Research — Columbus, Ohio, United States
• Hometown Urgent Care and Research — Dayton, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.